# Johnson & Johnson (JNJ) — Q2-2017 Earnings Results

**Report date:** 2017-07-18 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2017

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.83 | N/A | +0.14% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future performance. They emphasized the resilience of their core business areas.

**Key quotes:**

> Management highlighted ongoing strength in their pharmaceutical segment.

> They expressed confidence in their product pipeline despite market challenges.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson managed to exceed EPS expectations, indicating some operational strength. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the cautious tone from management suggests they are navigating a complex market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2017_